Neurogene Inc.

NGNE Stock Healthcare Biotechnology
$23.25
-0.70 (-2.92%)
Price as of Oct 16, 2026 market close

Performance

1 Month
-28.3%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Largest decline max drawdown, since Aug 2026
-47.2%

Own NGNE?

See how NGNE contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.